Health Care Industry
Industry: Email Alert RSS FeedPurepac receives approval for Spironolactone tablets
Drug Store News, Sept 27, 1999
Purepac Pharmaceutical Co., a subsidiary of FH Faulding & Co. Limited, has received FDA approval for its ANDA for Spironolactone tablets USP, 50 mg and 100 mg, the generic equivalent of Aldactone brand tablets marketed by Searle. Spironolactone is a pharmacological antagonist of the hormone aldosterone and acts as a diuretic and anti-hypertensive drug by this mechanism.
Most RecentHealth Care Articles
The product is indicated in the management of primary hyperaldosteronism and edematous conditions for patients with a number of conditions, including congestive heart failure.
COPYRIGHT 1999 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- 50 home remedies that work: these safe, fast, and effective fixes will relieve what ails you - Cover Story
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
- La anemia falciforme - causas y tratamiento
Most Popular Health Publications
Content provided in partnership with
